LMH STRATEGIC SOLUTIONS

Lobbying for STEALTH BIOTHERAPEUTICS INC. · Biotechnology company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $30,000.00 income · posted Oct 20, 2025

Bills named in this filing 2

Lobbying activity 1

Health Issues

FDA process issues. H.R.1262/S.932 - Give Kids a Chance Act of 2025.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.